Similar Stories to Why Cellect Biotechnology Stock Is Skyrocketing Today on Bing News

Cellect Biotechnology (NASDAQ: APOP), an Israeli-based stem-cell company, today announced the first successful stem cell transplant procedure using its ApoGraft technology in a combined phase 1/2 clinical trial in a blood cancer patient, causing its shares to rise by as much as 115%. The company's stock has since cooled off, but is still up by 80% as of 3:00 p.m.

BING NEWS:
  • Bio-Techne Is the Best Performing Stock in the S&P 500 Wednesday. Here’s Why.
    Bio-Techne stock was surging Wednesday after the biotechnology company reported better fiscal third-quarter financial results than Wall Street expected. Shares of Bio-Techne were up 17% to $74.18, in ...
    05/1/2024 - 6:52 am | View Link
  • Stock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices Plunge
    While a weakening economy and a subsequent dip in the stock market are unfortunate, they are inevitabilities. Even booming segments like the biotech sector are not immune to the general trend of ...
    05/1/2024 - 4:59 am | View Link
  • MAIA Biotechnology Shares Hit 52-Week High After Director Stock Purchase
    By Chris Wack MAIA Biotechnology shares hit their 52-week high Monday after it said that independent director Stan Smith made an individual purchase ...
    04/29/2024 - 6:04 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News